D-Glutamate

D-Glutamate

SCHEMBL2201557

NC(CCC(=O)O)C(=O)O.O=C(O)C1CCCN1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of D-Glutamate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.55
GRM6 O15303 2/20 0.55
GRM7 Q14831 2/20 0.55
GRM4 Q14833 2/20 0.55
GRIN2D O15399 1/20 0.55
GRIN3B O60391 1/20 0.55
GSR P00390 1/20 0.55
CYP1A2 P05177 1/20 0.55
GRIK1 P39086 1/20 0.55
GRM5 P41594 1/20 0.55
GRIA1 P42261 1/20 0.55
GRIA2 P42262 1/20 0.55
GRIA3 P42263 1/20 0.55
SLC1A3 P43003 1/20 0.55
SLC1A2 P43004 1/20 0.55
SLC1A1 P43005 1/20 0.55
GRIA4 P48058 1/20 0.55
GRIN1 Q05586 1/20 0.55
GRIN2A Q12879 1/20 0.55
GRIK2 Q13002 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL515160 1.00 GRM8 (0.55) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL27218911 1.00 GRM8 (0.55) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL16290410 1.00 GRM8 (0.55) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL27572769 1.00 GRM8 (0.55) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL194964 0.96 GRM8 (0.50) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL27622200 0.96 GRM8 (0.50) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL19856868 0.94 GRM8 (0.49) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL29255769 0.94 CYP1A2 (0.49) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL19856866 0.94 GRM8 (0.49) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL8852502 0.94 CYP1A2 (0.49) GRM8GRM6GRM7GRM4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891771-A1 Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases Health Now, Inc. (US) 1999-01-20 EP claimed
US-4761471-A INDUCE BONE FORMATION IN ANIMALS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1988-08-02 US claimed
US-20210060116-A1 PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES UNIV INDIANA RES & TECH CORP (US) 2021-03-04 US disclosed
US-10864244-B2 Peptides and methods for treatment of neurodegenerative diseases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2020-12-15 US disclosed
CN-108658243-B Method for quickly removing organic pollutants in coal gas wastewater 天津科技大学 2020-07-03 CN disclosed
US-20190054137-A1 PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION 2019-02-21 US disclosed
CN-108658243-A A kind of method of quick removal coal gas wastewater organic pollution 天津科技大学 2018-10-16 CN disclosed
WO-2017147044-A1 PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2017-08-31 WO disclosed
US-7977550-B2 Non-toxic endophytes, plants injected therewith and methods for injecting plants THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2011-07-12 US disclosed
US-20090255015-A1 NON-TOXIC ENDOPHYTES, PLANTS INJECTED THEREWITH AND METHODS FOR INJECTING PLANTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS 2009-10-08 US disclosed
US-7553654-B2 Non-toxic endophytes, plants injected therewith and methods for injecting plants THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2009-06-30 US disclosed
US-20020094996-A1 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases RATH MATTHIAS (NL) 2002-07-18 US disclosed
WO-2002028379-A2 COMPOSITIONS AND METHODS FOR LOWERING PLASMA LIPOPROTEIN(A) AND RISK FACTORS OF CARDIOVASCULAR DISEASES RATH MATTHIAS (US) 2002-04-11 WO disclosed
WO-2002013616-A2 PLANTS INFECTED WITH NON-TOXIC ENDOPHYTES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) 2002-02-21 WO disclosed
US-5976861-A PROTEINS FOR THE ISOLATION OF ANTIBODIES. PHARMACIA BIOTECH AKTIEBOLAG (SE) 1999-11-02 US disclosed
EP-0891771-A1 Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases Health Now, Inc. (US) 1999-01-20 EP disclosed
US-5438120-A Purified Bordetella pertussius antigen used in vaccine against whooping cough; side effect reduction BURROUGHS WELLCOME CO. (US) 1995-08-01 US disclosed
US-5141870-A Transforming plants with mutant fragment confers herbicide resistance E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-25 US disclosed
US-5013659-A Hybrid to resist sulfonylureas E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-07 US disclosed
US-5000953-A Biologically active substance KAKEN CHEMICAL CO., LTD. (JP) 1991-03-19 US disclosed